Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer

被引：0
|
作者：
Xiaohe Su
Kaifeng Jin
Qiji Guo
Ziyue Xu
Zhaopei Liu
Han Zeng
Yiwei Wang
Yu Zhu
Le Xu
Zewei Wang
Yuan Chang
Jiejie Xu
机构：
[1] Fudan University,NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences
[2] Fudan University,Department of Urology, Zhongshan Hospital
[3] Fudan University Shanghai Cancer Center,Department of Urology
[4] Shanghai Jiao Tong University School of Medicine,Department of Urology, Shanghai Ninth People’s Hospital
[5] Shanghai Jiao Tong University School of Medicine,Department of Urology, Ruijin Hospital
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：852 / 860
页数：8
相关论文
共 50 条
  • [21] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [22] Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action
    Xue, Yingyan
    Gao, Song
    Gou, Jingxin
    Yin, Tian
    He, Haibing
    Wang, Yanjiao
    Zhang, Yu
    Tang, Xing
    Wu, Rong
    EXPERT OPINION ON DRUG DELIVERY, 2021, 18 (02) : 187 - 203
  • [23] Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Li, Jingwei
    Ge, Fei
    Chiang, Huai-Chin
    Zhang, Xiaowen
    Zhang, Chi
    Zhang, Deyi
    Yang, Jing
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [24] Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer
    Tu, Megan M.
    Ng, Terry L.
    De Jong, Horns C.
    Zuiverloon, Tahlita C. M.
    Fazzari, Francesco G. T.
    Theodorescu, Dan
    BLADDER CANCER, 2019, 5 (02) : 131 - 145
  • [25] New strategies with PD-1/PD-L1 blockade in lung cancer
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (SUPPL 3) : 54 - 58
  • [26] PD-L1/PD-1 blockade in breast cancer: The immunotherapy era
    Li, Chia-Jung
    Lin, Li-Te
    Hou, Ming-Feng
    Chu, Pei-Yi
    ONCOLOGY REPORTS, 2021, 45 (01) : 5 - 12
  • [27] Conventional chemotherapy combined with PD-1/PD-L1
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (SUPPL 3) : 60 - 63
  • [28] PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
    Yaghoubi, Neda
    Soltani, Arash
    Ghazvini, Kiarash
    Hassanian, Seyed Mahdi
    Hashemy, Seyed Isaac
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 312 - 318
  • [29] PD-1/PD-L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity
    Hosseinzadeh, Ramin
    Feizisani, Fahimeh
    Shomali, Navid
    Abdelbasset, Walid Kamal
    Hemmatzadeh, Maryam
    Gholizadeh Navashenaq, Jamshid
    Jadidi-Niaragh, Farhad
    Bokov, Dmitry O.
    Janebifam, Morteza
    Mohammadi, Hamed
    IUBMB LIFE, 2021, 73 (11) : 1293 - 1306
  • [30] PD-1/PD-L1 and DNA Damage Response in Cancer
    Kciuk, Mateusz
    Kolat, Damian
    Kaluzinska-Kolat, Zaneta
    Gawrysiak, Mateusz
    Drozda, Rafal
    Celik, Ismail
    Kontek, Renata
    CELLS, 2023, 12 (04)
12345